Selank — Deep Research (Cognitive & Nootropic)

Published · Researched 2026-09-21

Research file written 2026-09-20. Social-first methodology: community sources weighted before vendor pages.

1. Overview

Selank is a synthetic heptapeptide and the anxiolytic half of the classic Russian nootropic pair. It is an analogue of tuftsin — a four-residue immune-signaling tetrapeptide (discovered at Tufts University) — with the same Pro-Gly-Pro tail that protects Semax, bolted on to give bioavailability and stability. Like Semax it was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences (late 1990s–early 2000s).

In Russia it is a registered medicine: approved 2009 as nasal drops at 0.15%, moved to over-the-counter status in 2017, with an approved label covering anxiety states, unmotivated worry, asthenia, mood lability, sleep disturbance, and adjustment/stress disorders in adults (Brainflow 2026 guide). Everywhere else it is sold as a research chemical not for human use: lyophilized vials (typically 10 mg) and pre-mixed nasal sprays, plus US 503A compounded-pharmacy offerings (e.g., FormBlends).

Chemical identity: Thr-Lys-Pro-Arg-Pro-Gly-Pro. Headline mechanism discussed: GABA-related signaling and enkephalinase inhibition — with an important correction: Selank does not bind the benzodiazepine site, and no binding/electrophysiology study demonstrates the often-claimed "GABA-A positive allosteric modulation"; gene-expression work (Volkova et al., 2016) shows Selank producing a GABA-shaped gene-expression fingerprint (r = 0.86 correlation with GABA's pattern) rather than behaving like a GABA drug.

Variant alert: N-Acetyl Selank Amidate is a distinct analog (N-terminal acetylation + C-terminal amidation), not the same compound as Selank — do not let a seller treat the names as synonyms, and human results for native Selank don't automatically transfer (Medium 2026 buyer guide).

2. Social standing

Selank sits with Semax at the top of the June-2026 community-dataset scan (GitHub hukus/llimitless) — strongest nootropic-peptide anecdote-priority nodes, well above dihexa/adamax/pinealon.

  • Threads: @uncle.lat's 2026-05-09 post (86 likes, 44 replies) gives the canonical framing — Selank is the anxiolytic: calms worry, stabilizes mood, sharpens focus without sedation. @ganee's 2026-07-24 log captures the clumsy real-world side (spilling half a bottle = RM 100 gone). A 2026-09-15 Threads vendor reel (@jennmacpep for republic.peptide) markets Selank as "calm without shutting down" — vendor content riding the same organic framing.
  • Reddit/forums: recurring r/Nootropics threads; the "5 Best Peptides for Anxiety" Medium roundup (2026) places Selank as the #1 anxiolytic research peptide; buyer-guide FAQs address vial vs. spray and the N-Acetyl Selank Amidate distinction.
  • Recurring praise: calm without sedation is the headline everywhere; tolerability repeatedly reported as better than benzodiazepines in the Russian trials (Stroop performance unimpaired, benefit persisting a week after the last dose); no "shutting down" the way sedatives do.
  • Recurring complaints / failure modes: underwhelming results when users expect a focus/stimulant effect (it's not Semax); underdosing or short courses (the trial course was 14 days at 2.7 mg/day); the N-Acetyl Selank Amidate name confusion; vendor trustworthiness and price (same #1 pain point as the whole category, per Threads sourcing posts).
  • Overhyped warnings: the "works like a benzo without the downsides" pitch is oversimplified — no binding data supports the GABA-A PAM framing, and the three head-to-head benzo trials were open-label, run in one country, several by the developing institute, largest n=70 (Brainflow, 2026 — credit to that guide for publishing the limitations alongside the claims).
  • Representative quotes (paraphrased from observed sources): @uncle.lat (Threads, 2026-05-09): Selank = anxiolytic; removes worry, stabilizes mood, sharpens focus without feeling sedated. @jennmacpep (Threads, 2026-09-15): "For the days when you want your brain to calm down without shutting down." Brainflow (2026): "Taken together, Selank has the strongest anxiolytic evidence of anything sold as a research peptide" — with the caveat that against a Western Phase III program this is "not close."

3. Social validation — Tier 2

  • Threads (owner + enthusiast + vendor content): @uncle.lat explainer (86 likes / 44 replies); @ganee self-trial log; @jennmacpep vendor reel. Proves both organic discussion and commercial attention — the pair drives the category conversation.
  • Forums/guides: Medium 2026 buyer-guide series (vial vs. spray vs. amidate, pricing snapshot); the "5 Best Peptides for Anxiety" provider comparison (FormBlends/others, named pharmacies). Proves sustained consumer-side research.
  • Community dataset: June-2026 hukus/llimitless scan — top anecdote-priority node. Proves dense community signal vs. frontier peptides.
  • Published evidence file: three Russian head-to-head trials against benzodiazepines (Zozulya et al., 62 patients, Selank vs. medazepam — comparable anxiolysis plus activating/anti-asthenic effects; 60 patients, Selank vs. phenazepam 2.7 mg/day × 14 days — comparable relief, better tolerability, effect persisting a week post-course; 70 patients, Selank + phenazepam vs. phenazepam alone — earlier response, reduced benzo downsides, easier discontinuation). All open-label, Russian-only, small — but a harder test than anything else in this category faced.
  • Gap vs. Tier 1: Facebook Groups queries returned zero hits this run (query-index limitation) — the highest-signal social layer contributed nothing fresh. Tier 2, honestly flagged.

4. Key specs table

Spec Value Source/status
Amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin + PGP tail) Brainflow 2026 guide
Molecular weight ~751.9 g/mol Widely cited — UNVERIFIED against an observed source this run
Form Lyophilized powder vials (typically 10 mg); pre-mixed nasal sprays; Russian Rx/OTC nasal drops 0.15% Vendor pages; Russian registration
Community-reported dose (nasal) 300–900 mcg/day Brainflow guide — not medical guidance
Course shape (trial) 2.7 mg/day × 14 days; 10 mg vial ≈ one full course (~16 days at 600 mcg/day) Russian phenazepam-comparison trial; Brainflow math
Timing Flexible, including evening (unlike Semax) Community consensus
Variants Native Selank (the research molecule) vs. N-Acetyl Selank Amidate (distinct analog — not interchangeable) Medium 2026 buyer guide
Half-life Exact human t½ UNVERIFIED; no published head-to-head vs. amidated variant on any efficacy endpoint Brainflow 2026

5. Pricing (observed 2026-09-20)

Offer Price Source
Selank 10 mg vial $29.99 (code BRAINFLOW = 10% off) Everest Peptides via Brainflow guide
Selank 10 mg / 15 ml nasal spray £49.99 (free next-day UK delivery) UK SARMs, observed 2026-09-20
Selank 10 mg vial €37.99 (tax included) Particle Peptides, observed 2026-09-20
Selank 10 ml nasal spray R 499 (sold out at capture) Perfectly Healthy SA, observed 2026-09-20
Selank 0.20% 30 mg / 15 ml spray SGD 86 (out of stock, import) Ubuy Singapore, observed 2026-09-20
10 mg list prices, Aug 2026 snapshot $3.00–4.75/mg; after-code examples down to ~$2.38/mg Medium buyer guide
Compounded Selank 5 mg / month $297/month via named 503A partner pharmacy FormBlends (Medium piece)

Cost-to-run math (Brainflow): at 600 mcg/day, a 10 mg vial ≈ 16 days ≈ $1.90/day before discounts. Selank tends to be run in defined courses when something is going on, so a couple of vials often cover twelve months — it doesn't get run repeatedly the way Semax does. Marketplace used range: not observed — say so honestly.

6. What's included / what's needed

  • Vials (typically 10 mg) ship lyophilized; bacteriostatic water required, often sold separately (Particle Peptides notes their vials ship without mannitol filler, so the vial can look nearly empty — normal, not a short fill).
  • For nasal use: nasal spray bottle or mucosal atomizer to transfer reconstituted solution.
  • Pre-mixed sprays: check label for exact molecule, total peptide mass, concentration, volume, metered amount per spray, excipients, lot number — if total peptide mass is missing, cost-per-mg can't be calculated (Medium 2026 buyer guide).

7. Support reality

  • COA culture: same bar as Semax — named third-party lab, certificate readable before payment, milligram content on the vial; walk away from blended acetylated Semax+Selank sprays (Brainflow). The Medium buyer guide's label checklist (molecule, mass, concentration, metered spray, lot, matching test evidence) is the practical standard.
  • Gray-market risk: research-use-only outside Russia; no pharmacy QA chain on gray-market product; the N-Acetyl Selank Amidate name-substitution problem (distinct analog sold as if it were Selank); blended-spray mislabeling risk.
  • Regulatory support asymmetry: unlike Semax, Selank's 503A nomination was withdrawn and PCAC never voted on it (Brainflow 2026) — US compounding access is weaker/none.

8. Community verdict

Selank is the community's calm-side default — the anxiolytic half of the Russian pair with, remarkably, three head-to-head human trials against benzodiazepines behind it. The honest consensus: genuine calm-without-sedation in defined courses, generally well-tolerated, and the least "hype-inflated" of the nootropic peptides precisely because its evidence file is real. Buy native Selank, not the amidate analog, and size to one 10 mg course at a time — that's all most users ever need.

9. Regulatory & safety status

  • Russia: registered medicine 2009 as nasal drops 0.15%; over-the-counter since 2017; approved label covers anxiety states, unmotivated worry, asthenia, mood lability, sleep disturbance, adjustment/stress disorders in adults (Brainflow 2026 guide).
  • USA: not FDA approved; PCAC nomination withdrawn, never voted on — no 503A compounding pathway (unlike Semax). WADA S0 category — treat as prohibited for tested athletes.
  • EU/UK: not EMA approved; gray-market research chemical only.
  • Community-reported safety: generally reported well-tolerated across community reports and the Russian trials (better tolerability than the benzodiazepines tested against; no Stroop impairment; no sedation signature). No long-term controlled safety data in healthy adults using it off-label; Russian trials were small, open-label, and in clinical populations. Do not taper or replace any prescribed medication without a prescriber — the third (combination) trial is not permission to taper a benzodiazepine on your own (Brainflow).

Images

7/8 views present in img/: selank-hero.jpg, selank-side.jpg, selank-rear.jpg, selank-top.jpg, selank-detail.jpg, selank-scale.jpg, selank-nasal-format.jpg. Honest assignment: selank-nasal-format.jpg is a vendor product-format shot of a "Pepti SELANK" nasal spray bottle — it documents the nasal format, not real-owner in-use; it is kept under its honest nasal-format name and does not stand in for the in-use view. Missing: box/accessories view (selank-box.jpg) — not yet gathered (see progress report).


Not medical advice. Community research only. Selank is not FDA/EMA approved; gray-market products carry quality and labeling risks. Never taper or replace prescribed medication without a prescriber — talk to a clinician before considering any peptide.

Selank — Deep Research (Cognitive & Nootropic) — detail view
detail view Original vendor page URL not recorded in research dossier
Selank — Deep Research (Cognitive & Nootropic) — hero view
hero view Original vendor page URL not recorded in research dossier
Selank — Deep Research (Cognitive & Nootropic) — nasal-format view
nasal-format view Original vendor page URL not recorded in research dossier
Selank — Deep Research (Cognitive & Nootropic) — rear view
rear view Original vendor page URL not recorded in research dossier
Selank — Deep Research (Cognitive & Nootropic) — scale view
scale view Original vendor page URL not recorded in research dossier
Selank — Deep Research (Cognitive & Nootropic) — side view
side view Original vendor page URL not recorded in research dossier
Selank — Deep Research (Cognitive & Nootropic) — top view
top view Original vendor page URL not recorded in research dossier

Named sources

  • Brainflow 2026 guide — Amino acid sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin + PGP tail) (2026)
  • Widely cited — Molecular weight: ~751.9 g/mol — UNVERIFIED against an observed source this run
  • Vendor pages — Form: Lyophilized powder vials (typically 10 mg); pre-mixed nasal sprays; Russian Rx/OTC nasal drops 0.15%
  • Russian registration — Form: Lyophilized powder vials (typically 10 mg); pre-mixed nasal sprays; Russian Rx/OTC nasal drops 0.15%
  • Brainflow guide — Selank 10 mg vial | **$29.99** (code BRAINFLOW = 10% off) | Everest Peptides via Brainflow guide | | Selank 10 mg / 15 ml nasal spray | **£49.99** (free next-day UK delivery) | UK SARMs, observed 2026-09-20 | | Selank 10 mg vial | **€37.99** (tax included) |… (2026-09-20)
  • Russian phenazepam-comparison trial — Course shape (trial): 2.7 mg/day × 14 days; 10 mg vial ≈ one full course (~16 days at 600 mcg/day)
  • Brainflow math — Course shape (trial): 2.7 mg/day × 14 days; 10 mg vial ≈ one full course (~16 days at 600 mcg/day)
  • Community consensus — Timing: Flexible, including evening (unlike Semax)
  • Medium 2026 buyer guide — Variants: Native Selank (the research molecule) vs. (2026)
  • Brainflow 2026 — Half-life: Exact human t½ **UNVERIFIED**; no published head-to-head vs. amidated variant on any efficacy endpoint (2026)
  • Threads @uncle.lat — @uncle.lat's 2026-05-09 post (86 likes, 44 replies) gives the canonical framing — Selank is the anxiolytic: calms worry, stabilizes mood, sharpens focus *without sedation*. (2026-05-09)
  • @ganee — @ganee's 2026-07-24 log captures the clumsy real-world side (spilling half a bottle = RM 100 gone). (2026-07-24)
  • Threads @jennmacpep — A 2026-09-15 Threads vendor reel (@jennmacpep for republic.peptide) markets Selank as "calm without shutting down" — vendor content riding the same organic framing. (2026-09-15)
  • Medium roundup — recurring r/Nootropics threads; the "5 Best Peptides for Anxiety" Medium roundup (2026) places Selank as the #1 anxiolytic research peptide; buyer-guide FAQs address vial vs. (2026)
  • Threads — @uncle.lat's 2026-05-09 post (86 likes, 44 replies) gives the canonical framing — Selank is the anxiolytic: calms worry, stabilizes mood, sharpens focus *without sedation*. @ganee's 2026-07-24 log captures the clumsy real-world side (spilling half a bottle =… (2026-05-09)
  • Reddit/forums — recurring r/Nootropics threads; the "5 Best Peptides for Anxiety" Medium roundup (2026) places Selank as the #1 anxiolytic research peptide; buyer-guide FAQs address vial vs. spray and the N-Acetyl Selank Amidate distinction. (2026)
  • Threads (owner + enthusiast + vendor content) — @uncle.lat explainer (86 likes / 44 replies); @ganee self-trial log; @jennmacpep vendor reel.
  • Forums/guides — Medium 2026 buyer-guide series (vial vs. spray vs. amidate, pricing snapshot); the "5 Best Peptides for Anxiety" provider comparison (FormBlends/others, named pharmacies). (2026)
  • Community dataset — June-2026 hukus/llimitless scan — top anecdote-priority node. (2026)

Source URLs were not recorded for these references.